Have a personal or library account? Click to login
The Healthcare Study Examines the Humoral Anti-S1 Antibody Response Following mRNA Vaccination, Comparing Individuals with and without Prior SARS-CoV-2 Infection Cover

The Healthcare Study Examines the Humoral Anti-S1 Antibody Response Following mRNA Vaccination, Comparing Individuals with and without Prior SARS-CoV-2 Infection

Archivum Immunologiae et Therapiae Experimentalis
Volume 72 (2024): Issue 1 (January 2024)
By: Małgorzata Staruszkiewicz,  Anna Pituch-Noworolska,  Mohamad Skayne,  Torsten Matthias and  Szymon Skoczen  
Open Access
|Aug 2024

Authors

Małgorzata Staruszkiewicz

Department of Pathology, University Children’s Hospital, Krakow, Poland

Anna Pituch-Noworolska

Department of Immunology, University Children’s Hospital, Krakow, Poland

Mohamad Skayne

AESKU. Diagnostics GmbH & Co. KG, Sales and Marketing Department, Wendelsheim, Germany

Torsten Matthias

Department of Immunology, University Children’s Hospital, Krakow, Poland

Szymon Skoczen

szymon.skoczen@uj.edu.pl

Department of Pediatric Oncology and Hematology, Institute of Pediatrics, Jagiellonian University, Medical College, Krakow, Poland
Department of Oncology and Hematology, University Children’s Hospital, Krakow, Poland
DOI: https://doi.org/10.2478/aite-2024-0016 | Journal eISSN: 1661-4917
Journal RSS Feed
Language: English
Submitted on: Feb 27, 2024
Accepted on: Jun 5, 2024
Published on: Aug 15, 2024
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
SARS-CoV-2,
COVID-19,
S1 protein,
Vaccine,
Antibodies,
Immunoglobulins
Related subjects:
Medicine,
Basic medical science,
Biochemistry,
Immunology,
Clinical medicine,
Clinical medicine, other,
Clinical chemistry

© 2024 Małgorzata Staruszkiewicz, Anna Pituch-Noworolska, Mohamad Skayne, Torsten Matthias, Szymon Skoczen, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 72 (2024): Issue 1 (January 2024)Next article